Drugs / HER-2/neu intracellular domain protein
HER-2/neu intracellular domain protein
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00363012 | Apr 2006 → Mar 2010 | breast cancer | University of Washington | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HER-2/neu intracellular domain protein | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00363012 ↗ |
| Modality | Protein / enzyme biologic | “HER-2/neu intracellular domain protein” NCT00363012 ↗ |
| Route | Other | “This will be injected intradermally on the back at 6 months post active immunization.” NCT00363012 ↗ |